Profile data is unavailable for this security.
About the company
Beijing Kawin Technology Share-Holding Co Ltd is a China-based company mainly engaged in the research and development, production and sales of innovative drugs. The Company focuses on the field of viruses and immune diseases. The Company's main products include kelopivir Hydrochloride Capsules, Peigun Interferon α-2 Injection, sofosbuvir Tablets, human interferon α2b vaginal effervescent Tablets, human interferon α2b injection, avatracopag maleate Tablets, Compound glycyrrhizin Capsules, Compound glycyrrhizin Tablets, Compound glycyrrhizin Injection, pirfenidone Tablets, and others. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)1.15bn
- Net income in CNY136.81m
- Incorporated2008
- Employees600.00
- LocationBeijing Kawin Technology Share-Holding Co LtdNo. 6 Rongjing East Street, EconomicTechnological Development ZoneBEIJING 100176ChinaCHN
- Phone+86 1 067892271
- Fax+86 1 067892271
- Websitehttps://www.kawin.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Fudan Forward S&T Co Ltd | 661.28m | -119.02m | 3.62bn | 1.41k | -- | 5.82 | -- | 5.48 | -0.1744 | -0.1744 | 0.9721 | 0.9158 | 0.4268 | 0.8015 | 9.29 | 467,663.00 | -7.83 | -3.33 | -14.36 | -5.82 | 32.05 | 39.99 | -18.35 | -7.67 | 0.4787 | -12.63 | 0.4378 | -- | -5.05 | -14.35 | -509.42 | -- | -18.59 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.15bn | 136.81m | 3.76bn | 600.00 | 27.91 | 2.05 | -- | 3.28 | 0.789 | 0.789 | 6.61 | 10.73 | 0.4166 | 1.52 | 2.64 | 1,910,937.00 | 5.26 | 5.55 | 7.12 | 7.14 | 81.89 | 84.98 | 12.64 | 9.40 | 2.55 | -- | 0.2017 | 45.97 | -12.87 | 8.32 | 22.18 | 21.60 | 40.30 | -- |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 790.86m | 226.35m | 3.90bn | 738.00 | 17.02 | 2.95 | -- | 4.93 | 0.6997 | 0.6997 | 2.46 | 4.04 | 0.4508 | 1.95 | 20.88 | -- | 13.02 | 11.48 | 15.87 | 14.03 | 68.99 | 69.02 | 28.88 | 24.63 | 0.985 | -- | 0.0808 | 37.22 | 6.36 | 0.9546 | 23.21 | 8.84 | -20.09 | 11.39 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.79bn | 46.95m | 3.91bn | 2.21k | 77.05 | 2.45 | -- | 2.19 | 0.0884 | 0.0884 | 3.31 | 2.78 | 0.4791 | 2.74 | 1.60 | 807,429.60 | 1.45 | 0.3241 | 3.13 | 0.6105 | 23.45 | 26.22 | 3.02 | 0.6331 | 0.9038 | 1.86 | 0.3592 | 52.82 | -6.21 | 8.16 | 16.00 | 2.61 | -19.14 | -- |
Data as of Feb 12 2026. Currency figures normalised to Beijing Kawin Technology Share-Holding Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2025 | 6.47m | 5.68% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2025 | 2.28m | 2.01% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 1.29m | 1.14% |
| Bodao Fund Management Co Ltd.as of 30 Jun 2025 | 1.26m | 1.11% |
| HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2025 | 1.15m | 1.02% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.15m | 1.01% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 1.04m | 0.91% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 785.06k | 0.69% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 443.93k | 0.39% |
| Fuanda Fund Management Co., Ltd.as of 30 Jun 2025 | 227.47k | 0.20% |
More ▼
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
